Sort
25,944 grants matching “neurodegeneration”
Mechanism of mitochondria-induced cell degeneration in the central nervous system
$405,000Xin Jie Chen · Upstate Medical University · R56 · FY2017 · AG
Function and regulation of copper in mammalian tissue differentiation
$405,000Katherine Elizabeth Vest · University Of Cincinnati · R35 · FY2023 · GM
A transcription factor complex specifically induced in neurodegeneration
$405,000Ulrich Hengst · Columbia University Health Sciences · R01 · FY2020 · NS
Dissecting the Molecular Mechanisms of Selective Autophagy
$405,000Michael Joseph Ragusa · Dartmouth College · R35 · FY2021 · GM
TDP-43 Proteinopathy in ALS-FTD: Mechanism, Target Validation and Biomarker
$405,000Philip C Wong · Johns Hopkins University · R01 · FY2016 · NS
Sustained-release of novel neuroprotective agents for treatment of glaucoma
$405,000Laura Ensign · Johns Hopkins University · R01 · FY2017 · EY
Neurocognitive Consequences of Intermittent Hypoxia
$405,000Alfredo J Garcia · University Of Chicago · R01 · FY2020 · NS
Structure and Regulatory Mechanisms of the Vacuolar ATPase
$405,000Stephan Wilkens · Upstate Medical University · R35 · FY2023 · GM
TDP-43 Proteinopathy in ALS-FTD: Mechanism, Target Validation and Biomarker
$405,000Philip C Wong · Johns Hopkins University · R01 · FY2018 · NS
Sustained-release of novel neuroprotective agents for treatment of glaucoma
$405,000Laura Ensign · Johns Hopkins University · R01 · FY2020 · EY
Sustained-release of novel neuroprotective agents for treatment of glaucoma
$405,000Laura Ensign · Johns Hopkins University · R01 · FY2016 · EY
Function and regulation of copper in mammalian tissue differentiation
$405,000Katherine Elizabeth Vest · University Of Cincinnati · R35 · FY2022 · GM
Function and regulation of copper in mammalian tissue differentiation
$405,000Katherine Elizabeth Vest · University Of Cincinnati · R35 · FY2025 · GM
Function and regulation of copper in mammalian tissue differentiation
$405,000Katherine Elizabeth Vest · University Of Cincinnati · R35 · FY2024 · GM
Sustained-release of novel neuroprotective agents for treatment of glaucoma
$405,000Laura Ensign · Johns Hopkins University · R01 · FY2019 · EY
TDP-43 Proteinopathy in ALS-FTD: Mechanism, Target Validation and Biomarker
$405,000Philip C Wong · Johns Hopkins University · R01 · FY2017 · NS
Dissecting the Molecular Mechanisms of Selective Autophagy
$405,000Michael Joseph Ragusa · Dartmouth College · R35 · FY2018 · GM
TDP-43 Proteinopathy in ALS-FTD: Mechanism, Target Validation and Biomarker
$405,000Philip C Wong · Johns Hopkins University · R01 · FY2020 · NS
Structure and Regulatory Mechanisms of the Vacuolar ATPase
$405,000Stephan Wilkens · Upstate Medical University · R35 · FY2024 · GM
Dissecting the Molecular Mechanisms of Selective Autophagy
$405,000Michael Joseph Ragusa · Dartmouth College · R35 · FY2022 · GM
TDP-43 Proteinopathy in ALS-FTD: Mechanism, Target Validation and Biomarker
$405,000Philip C Wong · Johns Hopkins University · R01 · FY2019 · NS
Structure and Regulatory Mechanisms of the Vacuolar ATPase
$405,000Stephan Wilkens · Upstate Medical University · R35 · FY2025 · GM
Structure and Regulatory Mechanisms of the Vacuolar ATPase
$405,000Stephan Wilkens · Upstate Medical University · R35 · FY2022 · GM
A transcription factor complex specifically induced in neurodegeneration
$405,000Ulrich Hengst · Columbia University Health Sciences · R01 · FY2022 · NS
Sustained-release of novel neuroprotective agents for treatment of glaucoma
$405,000Laura Ensign · Johns Hopkins University · R01 · FY2018 · EY